Early Allogenic Transplantation Improves Overall Survival (OS) and Event Free Survival (EFS) Independently of the Applied Chemotherapy in AML Patients with Unfavourable Cytogenetic Karyotype

AML patients with unfavourable cytogenetics generally have a poor outcome. Over the last decade a number of strategies to improving survival have been assessed by the East German Study Group (OSHO). Here, we analyse the results of three protocols (AML 93, AML 96 and AML 2002) for effects on outcome...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2006-11, Vol.108 (11), p.1921-1921
Main Authors: Becker, Cornelia, Krahl, Rainer, Al Ali, Haifa, Heyn, Simone, Poenisch, Wolfram, Cross, Michael, Lange, Thoralf, Gerhardt, Anke, Schulze, Antje, Haehling, Detlev, Schulze, Manfred, Freund, Mathias, Kettner, Erika, Doelken, Gottfried, Assmann, Michael, Wolf, Hans-Heinrich, Zschuppe, Ernst, Peter, Norma, Franke, Astrid, Wedding, Ullrich, Uharek, Lutz, Kreibich, Ute, Grobe, Norbert, Ittel, Thomas, Florschuetz, Axel, Opitz, Bernhard, Senftleben, Kristiane, Schirmer, Veronika, Fenchel, Klaus, Fiedler, Friedrich, Huhn, Renate, Zojer, Niklas, Helbig, Werner, Niederwieser, Dietger
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AML patients with unfavourable cytogenetics generally have a poor outcome. Over the last decade a number of strategies to improving survival have been assessed by the East German Study Group (OSHO). Here, we analyse the results of three protocols (AML 93, AML 96 and AML 2002) for effects on outcome in younger patients (
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V108.11.1921.1921